Hong MH, Shin SJ, Shin SK, Kim DJ, Zo JI, Shim YM, Lee SE, Cho BC, Park SY, Choi YL, Kim HR. High CD3 and ICOS and low TIM-3 expression predict favourable survival in resected oesophageal squamous cell carcinoma. Scientific Reports. 2019 Dec.

Lee SE, Kim YJ, Sung M, Lee MS, Han J, Kim HK, Choi YL. Association with PD-L1 Expression and Clinicopathological Features in 1000 Lung Cancers: A Large Single-Institution Study of Surgically Resected Lung Cancers with a High Prevalence of EGFR Mutation. International Journal of Molecular Sciences. 2019 Sep.

Lee SE, Lee HS, Kim KY, Park JH, Roh H, Park HY, Kim WS. High prevalence of the MLH1 V384D germline mutation in patients with HER2-positive luminal B breast cancer. Scientific Reports. 2019 Jul.

Lee HS, Lee JW, Park JH, Kim WS, Han HS, Lee SE. Comprehensive analysis for diagnosis of preoperative non-invasive follicular thyroid neoplasm with papillary-like nuclear features. PLoS One. 2019 Jul.

Lee JY [et al.]. Role of MEL-18 Amplification in Anti-HER2 Therapy of Breast Cancer. Journal of the National Cancer Institute. 2019 Jun.

Lee SE, Park HY, Kwon D, Jeon YK, Kim WY. Blastic plasmacytoid dendritic cell neoplasm with unusual extracutaneous manifestation: Two case reports and literature review. Medicine. 2019 Feb.

Lee SE. Molecular breakdown: a comprehensive view of anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer. Journal of Pathology. 2017 Nov;243(3):307-19.

Lee SE, Shim SH, Kim WY. Dedifferentiated carcinoma with clear cell carcinoma of the endometrium: A case report. Pathology International. 2017 Sep;67(9):472-6.

Lee SE. MET Exon 14 Skipping Mutations in Lung Adenocarcinoma: Clinicopathologic Implications and Prognostic Values. Journal of Thoracic Oncology. 2017 Aug;12(8):1233-46.

Lee SE, Kim WY, Han HS, Lim SD, Kim WS, Yoo YB, Kim SK, Hwang TS. Molecular profiling of papillary thyroid carcinoma in Korea with high prevalence of BRAFV600E mutation. Thyroid. 2017 Jun;27(6):802-10.

Lee SE. Clinicopathologic Characteristics and Mutational Status of Succinate Dehydrogenase Genes in Paraganglioma of the Urinary Bladder: A Multi-Institutional Korean Study. Archives of Pathology & Laboratory Medicine. 2017 May;141(5):671-7.

Lee SE, Han HS, Kim WS, Kim SK, Park KS, Hwang TS. Diagnostic Limitation of Fine-Needle Aspiration (FNA) on Indeterminate Thyroid Nodules Can Be Partially Overcome by Preoperative Molecular Analysis: Assessment of RET/PTC1 Rearrangement in BRAF and RAS Wild-Type Routine Air-Dried FNA Specimens. International Journal of Molecular Sciences. 2017 Apr 12;18(4):806.

Lee,S.E.; Chang,S.H.; Kim,W.Y.; Lim,S.D.; Kim,W.S.; Hwang,T.S.; Han,H.S. Frequent somatic TERT promoter mutations and CTNNB1 mutations in hepatocellular carcinoma. Oncotarget. 2016, 7, 43, 69267-69275, United States.

Lee,S.E.; Hwang,T.S.; Choi,Y.L.; Han,H.S.; Kim,W.S.; Jang,M.H.; Kim,S.K.; Yang,J.H. Prognostic Significance of TERT Promoter Mutations in Papillary Thyroid Carcinomas in a BRAFV600E Mutation-Prevalent Population. Thyroid. 2016, 26, 7, 901-910, United States.

Lee,S.E.; Lee,S.Y.; Park,H.K.; Oh,S.Y.; Kim,H.J.; Lee,K.Y.; Kim,W.S. Detection of EGFR and KRAS Mutation by Pyrosequencing Analysis in Cytologic Samples of Non-Small Cell Lung Cancer. J.Korean Med.Sci. 2016, 31, 8, 1224-1230.

Kim,H.S.; Lee,S.E.; Bae,Y.S.; Kim,D.J.; Lee,C.G.; Hur,J.; Chung,H.; Park,J.C.; Shin,S.K.; Lee,S.K.; Lee,Y.C.; Kim,H.R.; Shim,Y.M.; Jewell,S.S.; Kim,H.; Choi,Y.L.; Cho,B.C. PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma. Oncotarget. 2016, 7, 21, 30691-30701.

Lee,S.E.; Oh,E.; Lee,B.; Kim,Y.J.; Oh,D.Y.; Jung,K.; Choi,J.S.; Kim,J.; Kim,S.J.; Yang,J.W.; An,J.; Oh,Y.L.; Choi,Y.L. Phenylethanolamine N-methyltransferase downregulation is associated with malignant pheochromocytoma/paraganglioma. Oncotarget. 2016, 7, 17, 24141-24153.

Lee,S.E.; Kang,S.Y.; Yoo,H.Y.; Kim,S.J.; Kim,W.S.; Ko,Y.H. Clonal relationships in recurrent B-cell lymphomas. Oncotarget. 2016, 7, 11, 12359-12371.